Plain-English translation of NCT02639702 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Schizophrenia research guide โPhase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This is a pilot study testing whether can be taken once daily instead of twice daily in people with schizophrenia or schizoaffective disorder. Currently, the medication instructions say to take it multiple times a day, but many doctors and patients already give it once daily because it's more convenient and may reduce side effects like daytime drowsiness. This study wants to know if once-daily dosing works just as well as the traditional twice-daily approach.
While other similar psychiatric medications have been proven to work well on a once-daily schedule, no one has formally studied whether this medication can safely be switched to once-daily dosing. Many doctors are already doing this in real practice, but we need proper research to confirm it's safe and effective.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will be randomly assigned to either switch to taking your medication once daily in the evening (with a gradual transition over two weeks) or to continue taking it twice daily. The study is double-blind, meaning neither you nor the researchers will know which group you're in. You will be monitored to see how well you feel, how your symptoms are controlled, and whether you experience any side effects on your assigned schedule.
AI-generated summary from trial data ยท Jun 11, 2026 ยท Not medical advice
Canada